Your session is about to expire
← Back to Search
Mind-Body Intervention
Tai Chi for Chronic Pain in Adults with HIV
N/A
Waitlist Available
Led By Eugene M Dunne, PhD
Research Sponsored by Temple University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (week 0), post-intervention (weeks 10-12), 3-month follow up (weeks 22-24)
Awards & highlights
No Placebo-Only Group
Summary
This trial will study if Tai Chi is an effective way to manage chronic pain for people with HIV.
Who is the study for?
This trial is for adults over 45 who are living with HIV and chronic pain, can speak English, and are physically able to do Tai Chi. They must be willing to consent, travel to the study site, and commit to a 10-week program. People with acute mental health crises or active substance use disorders cannot join.
What is being tested?
The study is testing whether Health Coaching and Tai Chi can help improve life quality for those living with HIV and chronic pain. It aims to provide an alternative to opioid-based treatments by exploring these non-drug approaches.
What are the potential side effects?
Since this trial involves non-pharmacological interventions like Health Coaching and Tai Chi, side effects may include muscle soreness or strain from physical activity but typically do not involve drug-related side effects.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (week 0), post-intervention (weeks 10-12), 3-month follow up (weeks 22-24)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (week 0), post-intervention (weeks 10-12), 3-month follow up (weeks 22-24)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Brief Pain Inventory - Short Form (BPI)
Orebro Musculoskeletal Pain Screening Questionnaire (OMSPQ)
Pain Rating (VAS)
+1 moreSecondary study objectives
Pain Catastrophizing Scale (PCS)
Patient Health Questionnaire (PHQ-8)
Perceived Stress Scale (PSS)
+3 moreOther study objectives
Acceptability
Feasibility
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Gentle MovementExperimental Treatment1 Intervention
Group II: Health CoachingActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tai Chi
2014
Completed Phase 2
~1660
Find a Location
Who is running the clinical trial?
Temple UniversityLead Sponsor
316 Previous Clinical Trials
89,230 Total Patients Enrolled
1 Trials studying Chronic Pain
17 Patients Enrolled for Chronic Pain
National Center for Complementary and Integrative Health (NCCIH)NIH
862 Previous Clinical Trials
674,065 Total Patients Enrolled
49 Trials studying Chronic Pain
20,403 Patients Enrolled for Chronic Pain
Eugene M Dunne, PhDPrincipal InvestigatorTemple University
1 Previous Clinical Trials
450 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are currently feeling very suicidal or are experiencing severe mental illness.You have a long-lasting pain condition documented in your medical records.You are 45 years old or older.You currently have a problem with using drugs or alcohol.You have been diagnosed with HIV.You are physically capable of joining a Tai Chi program.
Research Study Groups:
This trial has the following groups:- Group 1: Gentle Movement
- Group 2: Health Coaching
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.